617 related articles for article (PubMed ID: 15534562)
1. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
2. Remune. Immune Response.
Lai D; Jones T
Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
[TBL] [Abstract][Full Text] [Related]
3. Statistical evaluation of HIV vaccines in early clinical trials.
Moodie Z; Rossini AJ; Hudgens MG; Gilbert PB; Self SG; Russell ND
Contemp Clin Trials; 2006 Apr; 27(2):147-60. PubMed ID: 16426900
[TBL] [Abstract][Full Text] [Related]
4. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
[TBL] [Abstract][Full Text] [Related]
5. Remune trial will stop; new trials planned.
James JS
AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 immunogen (remune).
Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099
[TBL] [Abstract][Full Text] [Related]
7. Rebuilding immunity with Remune.
Whitfield L
Posit Aware; 1998; 9(3):39-40. PubMed ID: 11365486
[TBL] [Abstract][Full Text] [Related]
8. A primer on HIV type 1-specific immune function and REMUNE.
Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
[TBL] [Abstract][Full Text] [Related]
9. HIV vaccine research in Thailand: lessons learned.
Pitisuttithum P
Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
[TBL] [Abstract][Full Text] [Related]
10. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.
Thapinta D; Jenkins RA
Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444
[TBL] [Abstract][Full Text] [Related]
11. Support for the RV144 HIV vaccine trial.
Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
[No Abstract] [Full Text] [Related]
12. First large-scale U.S. trial of HIV vaccine begins soon.
AIDS Policy Law; 1998 Jun; 13(12):10. PubMed ID: 11365517
[TBL] [Abstract][Full Text] [Related]
13. Outstanding questions on HIV vaccine trial.
Jefferys R; Harrington M
Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
[No Abstract] [Full Text] [Related]
14. Support for the RV144 HIV vaccine trial.
AIDS Vaccine Advocacy Coalition
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
[No Abstract] [Full Text] [Related]
15. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
Agnew B
Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
[No Abstract] [Full Text] [Related]
16. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
WHO/UNAIDS/IAVI International Expert Group
AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
[TBL] [Abstract][Full Text] [Related]
17. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
[No Abstract] [Full Text] [Related]
18. HIV-specific immune responses restored by HIV immunogen plus antiretroviral suppression.
James JS
AIDS Treat News; 1998 Jul; (No 298):1-5. PubMed ID: 11365597
[TBL] [Abstract][Full Text] [Related]
19. Army HIV vaccine to undergo clinical trial as rival is halted.
Check E
Nature; 2002 Mar; 416(6876):6. PubMed ID: 11882860
[No Abstract] [Full Text] [Related]
20. A boost for the immune system.
TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]